CSIR-IICT played key role in developing adjuvant for Covaxin, says CSIR

The process technology developed by the Council Of Scientific and Industrial Research–Indian Institute Of Chemical Technology for the agonist molecule is playing an important role in the production of adjuvant for Bharat Biotech's COVID-19 vaccine Covaxin, the CSIR said on Friday. "The vaccine is formulated with Algel-IMDG, which contains chemisorbed TLR7/8 agonist onto aluminum hydroxide gel to generate the requisite type of immune responses," the CSIR said in a statement.

from IndiaTV India: Google News Feed https://ift.tt/3uB8qS2
via